Evidence map›Paper›PMID 30034855›Full record

ReviewJournal of thoracic disease2018

Telemonitoring of left-ventricular assist device patients-current status and future challenges.

Nils Reiss, Thomas Schmidt, Michael Boeckelmann, Sebastian Schulte-Eistrup, Jan-Dirk Hoffmann, Christina Feldmann, Jan D Schmitto

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of thoracic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04613401 (Association of Telemonitoring With Hospitalization Rates and Quality of Life in Patients With End-stage Heart Failure and Implanted Left Ventricular Cardiac Assist Devices), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04613401 unknown statusnot on this mapstarted 2020, after this paper: background citation

Association of Telemonitoring With Hospitalization Rates and Quality of Life in Patients With End-stage Heart Failure and Implanted Left Ventricular Cardiac Assist Devices

TypeobservationalSponsorUniversity Hospital, EssenRan2020 to 2021Enrolled50ConditionsHeart Failure, Ventricular Assist Device, TelemedicineArmsquestionnaire (observational study)
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Hybrid Mock Circulatory Loop Simulation of Extreme Cardiac Events.IEEE transactions on bio-medical engineering · 2022
    Article
  6. VAD Patients' Perception of Potential Telemedicine Support.International journal of environmental research and public health · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nils ReissDepartment for Clinical Research, Schüchtermann-Klinik Bad Rothenfelde, Bad Rothenfelde, Germany.
Thomas SchmidtDepartment for Clinical Research, Schüchtermann-Klinik Bad Rothenfelde, Bad Rothenfelde, Germany.
Michael BoeckelmannDepartment for Clinical Research, Schüchtermann-Klinik Bad Rothenfelde, Bad Rothenfelde, Germany.
Sebastian Schulte-EistrupDepartment for Clinical Research, Schüchtermann-Klinik Bad Rothenfelde, Bad Rothenfelde, Germany.
Jan-Dirk HoffmannDepartment for Clinical Research, Schüchtermann-Klinik Bad Rothenfelde, Bad Rothenfelde, Germany.
Christina FeldmannDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Jan D SchmittoDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

E-health, especially telemedicine, has undergone a remarkably dynamic development over the past few years. Most experience is currently in the field of telemedical care for heart failure (HF) patients. However, HF patients with an implanted left-ventricular assist device (LVAD) have been more or less excluded from consistent telemonitoring until now. And yet, continual monitoring would be very significant for this patient group because of the complexity of its aftercare, requiring steady control of various parameters (device-related parameters, vital parameters, coagulation parameters, etc.). With timely action, severe and costly complications like pump thromboses and driveline infections could be detected early on or even avoided completely. This paper describes the potential of telemonitoring in LVAD patients, as well as its first clinical implementation according to the available literature. It also describes the requirements for a complete telemonitoring of LVAD patients, facilitating the advancement of this form of continual monitoring to a clinical standard which would increase the quality of aftercare for this very special patient collective enormously.

Indexed as

aftercareHeart failure (HF)left ventricular assist device (LVAD)remote haemodynamic monitoringtelemonitoring

Identifiers

PMID30034855
PMCPMC6035944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.